A Study of Epcoritamab and Ibrutinib in People With Central Nervous System Lymphoma (CNSL)

Clinical trial NCT07082868 · RECRUITING

Trial details

NCT number: NCT07082868
Sponsor: Memorial Sloan Kettering Cancer Center
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Primary Central Nervous System Lymphoma (PCNSL)Primary Central Nervous System Lymphoma Relapsed Primary Central Nervous System Lymphoma Refractory Primary Central Nervous System Lymphoma Central Nervous System Lymphoma Secondary Central Nervous System Lymphoma Secondary Central Nervous System Lymphoma (SCNSL)

Start date: 2025-08-13
Primary completion: 2028-08-01
Enrollment: 26

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.